title: RG-1068 RepliGen.
abstract: RG-1068 is a synthetic form of the natural human hormone secretin under development by RepliGen for the potential treatment of autism. RG-1068 received Fast Track designation for the treatment of pediatric autism in September 2001, and in February 2002, it entered phase III clinical trials.
authors.affiliation: editor@greyowltutor.com
authors.forename: Glen
authors.initials: G
authors.lastname: Wheeler
mesh_terms: D000818:Animals; D001321:Autistic Disorder / Q000188:drug therapy*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D012633:Secretin / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D012633:Secretin